New ALS drug approved in Canada while still under FDA review
Boosting the immune response against cancer
13 June 2022Asthma attacks may be cut by half with digital tools
13 June 2022New ALS drug approved in Canada while still under FDA review
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.
